Ramirez Giuseppe A, Rovere-Querini Patrizia, Sabbadini Maria Grazia, Manfredi Angelo A
IRCCS Ospedale San Raffaele, via Olgettina 60, 20132, Milan, Italy.
Università Vita Salute San Raffaele, via Olgettina 58, 20132, Milan, Italy.
Arthritis Res Ther. 2015 Jan 28;17(1):16. doi: 10.1186/s13075-015-0528-2.
Sustained inflammation of the vessel walls occurs in a large number of systemic diseases (ranging from atherosclerosis to systemic vasculitides, thrombotic microangiopathies and connective tissue diseases), which are ultimately characterized by ischemia and end-organ failure. Cellular and humoral innate immunity contribute to a common pathogenic background and comprise several potential targets for therapeutic intervention. Here we discuss some recent advances in the effector and regulatory action of neutrophils and in the outcome of their interaction with circulating platelets. In parallel, we discuss novel insights into the role of humoral innate immunity in vascular inflammation. All these topics are discussed in light of potential clinical and therapeutic implications in the near future.
血管壁的持续炎症发生在大量全身性疾病中(从动脉粥样硬化到系统性血管炎、血栓性微血管病和结缔组织病),这些疾病最终的特征是缺血和终末器官衰竭。细胞和体液固有免疫促成了一个共同的致病背景,并且包含几个潜在的治疗干预靶点。在此,我们讨论中性粒细胞效应和调节作用以及它们与循环血小板相互作用结果方面的一些最新进展。同时,我们讨论体液固有免疫在血管炎症中作用的新见解。所有这些主题都结合近期潜在的临床和治疗意义进行讨论。